Facilitating breast-conserving surgery and preventing recurrence: aromatase inhibitors in the neoadjuvant and adjuvant settings

Annals of Surgical Oncology
Eleftherios P Mamounas

Abstract

Breast-conserving surgery (BCS) is an attractive option for many patients with early-stage breast cancer, because it provides a better cosmetic outcome than modified radical mastectomy, while reducing surgical morbidity. In patients with large, operable breast tumors who are ineligible for BCS, neoadjuvant therapy is a useful option for reducing the tumor size and for increasing the proportion of candidates for BCS. In patients with endocrine-responsive tumors, neoadjuvant endocrine therapy with either tamoxifen or an aromatase inhibitor (AI; anastrozole, letrozole, or exemestane) provides an alternative to neoadjuvant chemotherapy. Clinical trials have demonstrated the superiority of neoadjuvant AIs over tamoxifen in achieving a clinical response and increasing the frequency of BCS. In addition, adjuvant endocrine therapy with AIs, whether used as initial therapy instead of tamoxifen, in a switching strategy after 2-3 years of tamoxifen, or as extended adjuvant therapy after 5 years of adjuvant tamoxifen, has been shown in several randomized clinical trials to improve disease-free survival, reduce distant metastases and, in some cases, improve overall survival. The availability of the AIs for effective and well-tolerated neoad...Continue Reading

References

Jan 16, 1991·JAMA : the Journal of the American Medical Association
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S M SchollP Beuzeboc
Oct 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T SaphnerR Gray
Dec 18, 1996·Journal of the National Cancer Institute·R Peto
Jul 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B FisherN V Dimitrov
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B FisherH D Bear
Dec 23, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A MakrisH T Ford
Sep 24, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M ColleoniA Goldhirsch
Feb 9, 2000·Investigational New Drugs·K Dhingra
Oct 19, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ColleoniA Goldhirsch
Mar 22, 2001·Journal of the National Cancer Institute·H J StewartA P Forrest
Nov 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A van der HageL Duchateau
Feb 2, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W EiermannUNKNOWN Letrozole Neo-Adjuvant Breast Cancer Study Group
Feb 5, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·I S FentimanUNKNOWN EORTC
Feb 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G MustacchiUNKNOWN Italian Cooperative Group GRETA
Oct 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harry D BearUNKNOWN National Surgical Adjuvant Breast and Bowel Project Protocol B-27
Dec 23, 2003·Journal of General Internal Medicine·R Scott BraithwaiteNananda F Col
Mar 12, 2004·The New England Journal of Medicine·R Charles CoombesUNKNOWN Intergroup Exemestane Study
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen K ChiaIvo A Olivotto
Nov 3, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A SchneeweissG Bastert
Nov 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric P WinerMark R Somerfield
Dec 9, 2004·Clinical Breast Cancer·Jens HuoberDiethelm Wallwiener
Mar 4, 2005·Breast Cancer Research : BCR·Kathy Pritchard, Tim Whelan
Jul 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rinaa S PungliaHarold J Burstein
Jul 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathleen I Pritchard
Sep 21, 2005·Breast Cancer Research and Treatment·Zhenhuan ZhangHirotaka Iwase

❮ Previous
Next ❯

Citations

Jul 14, 2010·Surgical Oncology Clinics of North America·Harry D Bear
Jan 13, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Lisa Feldman BarrettPaul Hamilton
Oct 2, 2009·Clinical Medicine. Therapeutics·Monica MilaniDavid A Potter
Sep 29, 2020·Breast Care·Katja Krauss, Elmar Stickeler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

The Breast : Official Journal of the European Society of Mastology
Joseph GligorovPaul Goss
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
R Carpenter
The Breast : Official Journal of the European Society of Mastology
Jack Cuzick
© 2021 Meta ULC. All rights reserved